NCT06298357 2026-03-18
Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation
University of Alabama at Birmingham
Phase 1 Completed
Clinical Trials
1,553 trialsNCT00420563 2026-03-16
PAL-ANGI
Centre Oscar Lambret
Phase 2 Completed
NCT06072833 2026-03-16
Characterizing and Addressing Financial Toxicity in AYAs With Cancer
Columbia University
Phase NA Completed
NCT00580515 2026-03-13
Trial of Family Focused Grief Therapy in Palliative Care and Bereavement
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT03833167 2026-03-10
KEYNOTE-630
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT02423057 2026-03-06
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02840058 2026-03-06
ITHER
Centre Hospitalier Universitaire de Besancon
Phase NA Completed
NCT06048822 2026-03-06
Enhancing Cancer Survivorship With Pickleball
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT06248450 2026-03-06
YouCanPrefer
Linkoeping University
Phase NA Completed
NCT06340815 2026-03-06
Varian ProBeam Proton Therapy System Clinical Trial (Shandong)
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT05148078 2026-03-02
Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT01602380 2026-02-27
FALCON
AstraZeneca
Phase 3 Completed
NCT05377554 2026-02-27
Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery
Alume Biosciences, Inc.
Phase 3 Completed
NCT05564468 2026-02-27
Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer
Fred Hutchinson Cancer Center
Phase NA Completed
NCT06056791 2026-02-27
CaRe
Inmune Bio, Inc.
Phase 1/2 Completed
NCT03976362 2026-02-25
KEYLYNK-008
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT05024968 2026-02-25
Sintilimab in Cancer of Unknown Primary
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03466957 2026-02-20
Individual Approach in Gynecological Cancer Brachytherapy
Institute of Oncology Ljubljana
Phase NA Completed
NCT03964233 2026-02-18
A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab)
Boehringer Ingelheim
Phase 1 Completed
NCT06758011 2026-02-17
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
Roswell Park Cancer Institute
Phase NA Completed
NCT03388190 2026-02-13
METIMMOX
University Hospital, Akershus
Phase 2 Completed
NCT05490641 2026-02-13
Project KNOWN
The University of Texas at Arlington
Phase NA Completed
NCT02212860 2026-02-11
SIGNAL 2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT01534598 2026-02-10
FdCyd and THU for Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT04455698 2026-02-10
ENGAGE
University of Chicago
Phase NA Completed
NCT04966520 2026-02-10
Accelerated Neuromodulation to Alleviate Cognitive Deficits Due to Cancer Therapy
University of Iowa
Phase NA Completed
NCT06170385 2026-02-06
PEACE
University of Alberta
Phase NA Completed
NCT05360498 2026-02-03
Symptom Management for Rural-Urban Cancer Survivors and Caregivers
University of Arizona
Phase NA Completed
NCT06326554 2026-01-30
STEP2
University Health Network, Toronto
Phase NA Completed
NCT04260529 2026-01-29
CICILIA
Cytovation AS
Phase 1/2 Completed
NCT03872778 2026-01-28
NeoRay
Advanced Accelerator Applications
Phase 1/2 Completed
NCT02952248 2026-01-27
A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours
Boehringer Ingelheim
Phase 1 Completed
NCT03697304 2026-01-27
Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours
Boehringer Ingelheim
Phase 2 Completed
NCT07361458 2026-01-23
Modex, a Cloud-based, Centralized Health Economic Model Marketplace to Reduce Costs and Enhance Equity in Cancer
Arnold Consultancy & Technology, LLC
Phase NA Completed
NCT03752333 2026-01-22
CUPem
Imperial College London
Phase 2 Completed
NCT02807129 2026-01-21
AgElOn
CHU de Reims
Phase NA Completed
NCT04429490 2026-01-21
PESTIPAC
CHU de Reims
Phase NA Completed
NCT06230679 2026-01-16
Effectiveness of NESA in the Treatment of Cancer Survivors
University of Las Palmas de Gran Canaria
Phase NA Completed
NCT01445509 2026-01-15
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT03824158 2026-01-14
Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial
University of Pittsburgh
Phase NA Completed
NCT05276284 2026-01-14
TEMPLE
Rigshospitalet, Denmark
Phase 1/2 Completed
NCT07337486 2026-01-13
"Evaluation of a Non-Pharmacological Skin Care Intervention for the Prevention and Treatment of Skin Toxicities Caused by Immunotherapy in Cancer Patients"
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase NA Completed
NCT06299722 2026-01-08
STEEL
Aalborg University
Phase NA Completed
NCT01968109 2026-01-06
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Completed
NCT06381024 2026-01-05
MINERVA
Centre Hospitalier de Bligny
Phase NA Completed
NCT06443632 2026-01-02
WASPE Sleep Adjustment for Children Aged 0-4 Years Undergoing Radiation Therapy
Shandong Cancer Hospital and Institute
Phase NA Completed
NCT02131805 2025-12-30
Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT06013176 2025-12-29
BEST-PRO
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT07279792 2025-12-29
Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection
Ain Shams University
Phase 2/3 Completed
NCT06015009 2025-12-26
Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers
Chinese University of Hong Kong
Phase NA Completed